Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I & T using a population pharmacokinetic/pharmacodynamic model

There is an unmet need for prediction of treatment outcome or patient selection for [177Lu]Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). Quantification of the tumor exp...

Source: EJNMMI Physics - April 24, 2024 Category: Radiology Authors: Hinke Siebinga, Berlinda J. de Wit-van der Veen, Daphne M. V. de Vries-Huizing, Wouter V. Vogel, Jeroen J. M. A. Hendrikx and Alwin D. R. Huitema Tags: Original research Source Type: research